BIOMAT Database Logo BIOMAT Database Logo

Sulindac treatment for familial polyposis coli. 1985

R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior

UI MeSH Term Description Entries
D007192 Indenes A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.
D008297 Male Males
D003111 Colonic Polyps Discrete tissue masses that protrude into the lumen of the COLON. These POLYPS are connected to the wall of the colon either by a stalk, pedunculus, or by a broad base. Colonic Polyp,Polyp, Colonic,Polyps, Colonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013467 Sulindac A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects. Aclin,Apo-Sulin,Arthrobid,Arthrocine,Chibret,Clinoril,Copal,Kenalin,Klinoril,MK-231,Novo-Sundac,Nu-Sulindac,Sulindal,Apo Sulin,MK 231,MK231,Novo Sundac,Nu Sulindac

Related Publications

R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior
Sulindac in familial adenomatous polyposis.
October 1993, Lancet (London, England),
R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior
[Familial adenomatous polyposis and sulindac].
May 1993, Revista espanola de enfermedades digestivas,
R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior
Sulindac in familial adenomatous polyposis.
February 1994, Lancet (London, England),
R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior
Sulindac in familial adenomatous polyposis.
August 2002, The New England journal of medicine,
R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior
Sulindac and Erlotinib for Familial Adenomatous Polyposis.
August 2016, JAMA,
R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior
[Sulindac--drug therapy for familial adenomatous polyposis?].
January 1993, Medizinische Klinik (Munich, Germany : 1983),
R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior
Sulindac plus erlotinib for familial adenomatous polyposis.
May 2016, The Lancet. Oncology,
R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior
[Treatment with sulindac of adenomatous polyps in familial polyposis].
August 1995, Revista espanola de enfermedades digestivas,
R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior
Sulindac and Erlotinib for Familial Adenomatous Polyposis--Reply.
August 2016, JAMA,
R A Gonzaga, and F R Lima, and S Carneiro, and J Maciel, and M Amarante Júnior
[Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study].
April 1994, Schweizerische medizinische Wochenschrift,
Copied contents to your clipboard!